QUINLAN PAUL T (General Counsel and Secretary) sold 2.3% of their position (733.00 shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $30.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2026ACC: 0000907654-26-000029
Officer· General Counsel and Secretary
Since Aug 2024
-733.00
Net shares
Net seller
$30.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
733.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−733.00
Price / share
$41.30
Trade value
$30.27K
% of position
2.3%
3/16/2026
32.50K→31.77K
Total
Net shares
−733.00
Net value
-$30.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | S · Sale | −733.00 | $41.30 | $30.27K | 2.3% | 32.50K | 31.77K |
| Total | −733.00 | -$30.27K | ||||||
Derivative Transactions0
No derivative transactions reported